Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.67
-0.79 (-7.55%)
Mar 31, 2025, 1:11 PM EDT - Market open
Nuvectis Pharma Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$15.00
Upside
+55.12%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +96.48% | Mar 17, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $11 | Strong Buy | Maintains | $21 → $11 | +13.75% | Feb 25, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +117.17% | Aug 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +117.17% | May 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +117.17% | Sep 15, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +117.17% | Mar 7, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +117.17% | Feb 10, 2023 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +117.17% | Jul 13, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $21 | Strong Buy | Maintains | $14 → $21 | +117.17% | May 10, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +44.78% | Mar 2, 2022 |